Welcome : Guest

Grifols S.A. (Spain) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Grifols S.A., which is principally involved in Specialty Biopharmaceuticals Business. Illustrated with 83 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-02859
Price: $3500
Company Type: Public
Pages: 86
Date: October 2015
Market Data Tables: 83

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Grifols S.A.’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for USA and Canada, Spain, European Union, Rest of the World and Raw Materials and Others......3
Table 2: Grifols S.A.’s Sales by Business Segment Worldwide (2012-2014) in Percentage for Bioscience, Diagnostic, Hospital and Raw Material and Others......4
Table 3: Grifols S.A.’s Sales by Business Category Worldwide (2013-2014) in Percentage for Bioscience (Haemoderivatives and Other Haemoderivatives), Diagnostic (Transfusional Medicine and In Vitro Diagnosis), Hospital (Fluid Therapy and Nutrition and Hospital Supplies) and Raw Materials and Others......5
Pharmaceuticals......6
Table 4: Pharmaceuticals Market by Category Worldwide (2015)-Percentage Share Breakdown by Value for Biologics and Chemical Synthetic and Others......6
Table 5: Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value for Biologics, and Chemicals......7
Table 6: Drugs Market by Category Worldwide (2015)-Percentage Share Breakdown by Value for Biologics, Monoclonal Antibodies and Other Classes......8
Table 7: Pharmaceutical Drugs Market by Category in Germany (2014) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......9
Biopharmaceuticals......10
Table 8: Biopharmaceuticals Market by Region Worldwide (2015)-Percentage Share Breakdown by Value for Asia, Africa and Australia, Europe, US and Others......10
Biologics......11
Table 9: Biological Drugs Market by Product Segment Worldwide (2015)-Percentage Share Breakdown by Value for Daratumuma, Elotuzumab, MOR202 and SAR650984......11
Table 10: Biologics Therapeutic Classes Market by Category in China (2014) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......12
Table 11: Dermatology Biologics Market by Product Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......13
Table 12: No. of Biologics in Development by Therapeutic Area Worldwide (2014) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......14
Table 13: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......15
Biosimilars......16
Table 14: Biosimilars Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Filgrastim, New Biosimilars, and Somatropin......16
Injectables......17
Table 15: Injectable Products Market by Type in Europe (2014) - Percentage Breakdown by Value Sales for Biologics, Biosimilars, Branded Injectables and Generic Injectables......17
Table 16: Injectables Market by Segment Worldwide (2015)-Percentage Share Breakdown by Value for Biologics, Standard Injectables, Vaccines and Others......18
Immunoglobulin Drugs......19
Table 17: Immunoglobulin Market by Product Worldwide (2015)-Percentage Share Breakdown by Value for Flebogamma, Gammagard Liquid, Gamunex, Octagam, Privigen and Others......19
Table 18: Intravenous and Subcutaneous Immunoglobulin (IVIG & SCIG) Market by Indication in the US (2014) - Percentage Share Breakdown by Volume for CIDP (Chronic Inflammatory Demyelinating Polyneuropathy), CLL (Chronic Lymphocytic leukaemia), ITP (Idiopathic Thrombocytopenic Purpura), MMN (Multifocal Motor Neuropathy), PID (Primary Immune Deficiency) and Others......20
Table 19: Intravenous Immunoglobulin (IVIG) Market by Region Worldwide (2014) - Percentage Market Share Breakdown by Volume Sales for Australia, Canada, Europe (East & West) and New Zealand, US, Others (Excluding US (Including Japan))......21
Table 20: Intravenous Immunoglobulin (IVIG) Therapy by Disorders in the US (2014) - Percentage Market Share Breakdown by No. of Indications for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Chronic Lymphocytic Leukemia (CLL), Idiopathic Thrombocytopenic Purpura (ITP), Mismatch Negativity (MMN), Pelvic Inflammatory Disease (PID), and Others......22
Table 21: Intravenous Immunoglobulin (IVIG) Therapy Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales, for Europe, US, and Others......23
Table 22: Intravenous Immunoglobulin (IVIG) Therapy Market by Region Worldwide (2014) - Percentage Share Breakdown by Volume Sales, for Europe, US, and Others......24
Table 23: Intravenous Immunoglobulin (IVIG) Usage by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Hematology and Oncology, Immune Thrombocytopenic Purpura (ITP), Neurology, Pelvic Inflammatory Disease (PID), and Others......25
Plasma Products......26
Table 24: Plasma Derivatives Market by Region Worldwide (2014) - Percentage Share Breakdown by Value for Europe, North America, and Others......26
Table 25: Plasma Derivatives Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Albumin, Alpha-1 Proteinase Inhibitor (A1PI), Hyperimmune, Intravenous Immunoglobulin (IVIG), Plasma-Derived Factor VIII (PDFVIII) & Willebrand Factor (WFactor), Polymeric Immunoglobulin Receptor, and Others......27
Table 26: Plasma Market by Product Worldwide (2015) - Percentage Breakdown by Value for Albumin, Factor IX, Factor VIII, Hyperimmunes, Intravenous Immunoglobulin (IVIG), and Others......28
Table 27: Plasma Market by Products (excluding Recombinant Factors) Worldwide (2015)-Percentage Share Breakdown by Value for Albumin, Factor VIII, Intravenous Immunoglobulin (IVIG) and Others......29
Table 28: Plasma Market by Region (excluding Recombinant Factors) Worldwide (2015)-Percentage Share Breakdown by Value for Asia-Pacific, Europe, North America and Others......30
Table 29: Plasma Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia, Europe, and Middle East, USA, and Others......31
Table 30: Plasma Market by Segment in China (2014) - Percentage Share Breakdown by Value for Alpha-1 proteinase inhibitor (A1PI), Coagulation Factor IX, Coagulation Factor VIII, Fibrinogen, Human Albumin, Immunoglobulin for Intramuscular Injection, Intravenous Immunoglobulin (IVIG), Prothrombin Complex, and Specific Immunoglobulin......32
Table 31: Plasma Products Consumption by Type in China (2014) - Percentage Share Breakdown by Volume for Albumin, Factor VIII, Hyperimmunes (IM&IV), and Intravenous Immunoglobulin (IVIG)......33
Table 32: Plasma Products Consumption by Type in the US (2014) - Percentage Share Breakdown by Volume for Albumin, Factor IX (Plasma), Factor VIII, Hyperimmunes (IM&IV), and Intravenous Immunoglobulin (IVIG), and Others......34
Table 33: Plasma Proteins Market by Product Worldwide (2015)-Percentage Share Breakdown by Value for Albumin, Globulins and Others......35
Table 34: Plasma Proteins Market by Region Worldwide (2014) - Percentage Share Breakdown by Value for Africa, Asia-Pacific, Europe, Middle East, North America, Oceania, and South America......36
Table 35: Plasma-Based Product Market by Type in China (2014) - Percentage Share Breakdown by Value for Blood Coagulation Factor, Human Albumin, Human Immunoglobin, Hyperimmunes, and Others......37
Biopharmaceuticals......38
Table 36: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Johnson & Johnson Ltd., Lonza Group Ltd, Pfizer, Inc., Sanofi S.A., and Others......38
Biosimilars......39
Table 37: Market Shares of Leading Biosimilar Drug Producing Companies in Europe (2015)-Percentage Share Breakdown by Value for Hospira, Inc., Sandoz, Teva Pharmaceuticals Industries Ltd. and Others......39
Albumin......40
Table 38: Market Shares of Leading Albumin Providers in China (2014) - Percentage Breakdown by Value for Baxter International, Inc., China Biologic Products, Inc., China National Biotec Group (CNBG), CSL Behring, Grifols, S.A., Hualan Biological Engineering, Inc., Jiangsu Kangbao Medical Equipment Co, Ltd., Ningbo Shuanglin Mould Co, Ltd., Octapharma AG, Shanghai RAAS Blood Products Co, Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co, Ltd., Tonrol Biopharm Co, Ltd., and Others......40
Table 39: Market Shares of Leading Albumin Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Limited, Grifols, S.A., Kedrion S.p.A, and Octapharma AG......41
Table 40: Market Shares of Leading Human Albumin Companies in China (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., Chengdu Institute of Biological Products Co, Ltd., China Biologic Products, Inc., CSL Behring, Grifols, S.A., and Others......42
Erythropoietin (EPO)......43
Table 41: Market Shares of Leading Erythropoietin (EPO) Companies in China (2014) - Percentage Share Breakdown by Value for 3SBio, Inc., Beijing Four Rings Biopharmaceutical Co, Ltd., Kyowa Hakko Kirin Co, Ltd., North China Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co, Ltd., and Others......43
Fractionators......44
Table 42: Market Shares of Leading Fractionators (With Recombinant Factors) Worldwide (2014) - Percentage Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL, Ltd., Kedrion Biopharma, LFB Group, Octapharma AG, Talecris Plasma Resources (Grifols, Inc.), and Others......44
Table 43: Market Shares of Leading Fractionators (Without Recombinant Factor) Worldwide (2014) - Percentage Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL, Ltd., Kedrion Biopharma, LFB Group, Octapharma AG, Talecris Plasma Resources (Grifols, Inc.), and Others......45
Table 44: Market Shares of Leading Fractionators in China (2014) - Percentage Breakdown by Value for Baxter International, Inc., China Biologic Products, Inc., China National Biotec Group, CSL Behring, Grifols, S.A., Hualan Biological Engineering, Inc., Jiangsu Kangbao Medical Equipment Co, Ltd., Ningbo Boya Medical Equipment Co, Ltd., Ningbo Shuanglin Mould Co, Ltd., Octapharma AG, Shanghai RAAS Blood Products Co, Ltd., Shuyang Group, Tonrol Biopharm Co, Ltd., and Others......46
Table 45: Market Shares of Leading Factor VIII (With Recombinant Factor) Companies in China (2014) - Percentage Breakdown by Value for Bayer AG, China Biologic Products, Inc., Green Cross Corporation, Hualan Biological Engineering, Inc., and Shanghai RAAS Blood Products Co, Ltd.......47
Table 46: Market Shares of Leading Factor VIII (Without Recombinant Factor) Companies in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., Green Cross Corporation, Hualan Biological Engineering, Inc., and Shanghai RAAS Blood Products Co, Ltd.......48
Table 47: Market Shares of Leading Factor VIII Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Limited, Grifols, S.A., and Kedrion S.p.A......49
Immunoglobulin Drugs......50
Table 48: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Baxter International, Inc., Biotest AG, CSL Ltd., Grifols, S.A., Kedrion S.p.A., Octapharma AG and Others......50
Table 49: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in Europe (2015) - Percentage Breakdown by Value for Baxter International Inc., Biotest AG, CSL Ltd., Grifols, S.A (Incl.Talecris), Octapharma AG, and Others......51
Table 50: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Ltd., Grifols, S.A (Incl.Talecris), and Others......52
Table 51: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Therapy Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Baxter International, Inc., Biotest AG, CSL Limited, Grifols, S.A., Talecris Biotherapeutics, Inc., Kedrion S.p.A., Octapharma AG, and Others......53
Table 52: Market Shares of Leading Intravenous Immunoglobulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Jiangsu Kangbao Medical Equipment Co, Ltd., Ningbo Boya Medical Equipment Co, Ltd., Ningbo Shuanglin Mould Co, Ltd., Shanghai RAAS Blood Products Co, Ltd., Shuyang Group, Tonrol Biopharm Co, Ltd., and Others......54
Table 53: Market Shares of Leading Rabies Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co, Ltd., Ningbo Shuanglin Mould Co, Ltd., Shuyang Group, Tonrol Biopharm Co, Ltd., and Others......55
Table 54: Market Shares of Leading Tetanus Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co, Ltd., Shuyang Group, and Tonrol Biopharm Co, Ltd.......56
Table 55: Market Shares of Leading Immunoglobulin Providing Companies Worldwide (2015)-Percentage Share Breakdown by Value for Baxter International, Inc. (Gammagard Liquid and S/D), CSL Limited (Privigen, Carimune and Hizentra), Grifiols, S.A. (Flebogamma and Gamunex) and Others......57
Table 56: Market Shares of Leading Immunology/ Immunoglobulin Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Limited, Grifols, S.A., and Others......58
Table 57: Market Shares of Leading Hepatitis B Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co, Ltd., Ningbo Boya Medical Equipment Co, Ltd., Shuyang Group, Tonrol Biopharm Co, Ltd., and Others......59
Injectables......60
Table 58: Market Shares of Leading Injectable Manufacturers by Value Sales in France (2014) - Percentage Breakdown for Aguettant Limited, Baxter International, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Lake Forest Park Medical Clinic (LFP), Mylan Laboratories, Inc., Novartis International AG (Sandoz), Laboratoires PANPHARMA S.A., Sanofi S.A., and Others......60
Table 59: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A.,Teva Pharmaceutical Industries Ltd. and Others......61
Table 60: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......62
Table 61: Market Shares of Leading Injectable Manufacturers by Value Sales in Spain (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Ges Genericos Españoles Laboratorio S.A., Grifols, S.A, Hospira, Inc., Johnson & Johnson, Normon S.A., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......63
Table 62: Market Shares of Leading Injectable Manufacturers by Value Sales in the UK (2014) - Percentage Breakdown for Actavis Plc (Watson), AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Hospira, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......64
Insulin......65
Table 63: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co, Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......65
Table 64: Market Shares of Leading Insulin Companies in China (2015)-Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......66
Table 65: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......67
Table 66: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......68
Table 67: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......69
Table 68: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A. and Others......70
Table 69: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A. and Others......71
Table 70: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Cadila Pharmaceuticals Limited, Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Limited, Pfizer India Limited, Ranbaxy Laboratories Limited, Sanofi India Limited, Shreya Life Sciences Pvt. Ltd, USV Limited and Wockhardt Ltd.......72
Plasma Products......73
Table 71: Market Shares of Leading Plasma Companies in China (2014) - Percentage Share Breakdown by Volume for Chengdu Rongsheng Pharmaceuticals Co, Ltd., China Biologic Products, Inc., Hualan Biological Engineering, Inc., Shanxi Kangbao Biological Product Co, Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co, Ltd., Tonglu Biological Pharmaceutical Co, Ltd., and Others......73
Table 72: Market Shares of Leading Plasma Companies in the US (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., CSL Behring, Octapharma AG, Talecris Plasma Resources (Grifols, Inc.), and Others......74
Table 73: Market Shares of Leading Plasma Companies Worldwide (2015)-Percentage Share Breakdown by Value for Baxter International, Inc., CSL Limited, Grifols, S.A. and Other......75
Table 74: Market Shares of Leading Plasma Derivative Companies in the US (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., CSL, Ltd., Grilfols USA, and Octapharma AG......76
Table 75: Market Shares of Leading Plasma Derivative Companies Worldwide (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL, Ltd., Grilfols USA, Kedrion Biopharma, LFB, Octapharma AG, and Others......77
Table 76: Market Shares of Leading Plasma Treatment Companies Worldwide (2015)-Percentage Share Breakdown by Value for Applied Materials, Inc., Hitachi Kokusai Electric Inc., Tokyo Electron Limited and Others......78
Other Products......79
Table 77: Market Shares of Leading Hemophilia Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Baxter International, Inc., Bayer AG, CSL Limited, Grifols, S.A., Kedrion S.p.A, Novo Nordisk A/S, Octapharma AG, and Pfizer, Inc.......79
Table 78: Market Shares of Leading Immunohematology Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bio-Rad Laboratories, Inc., Grifols, S.A., Immucor, Inc., Ortho Clinical Diagnostics, and Others......80
Table 79: Market Shares of Leading Nerve Growth Factor (NGF) Companies in China (2014) - Percentage Share Breakdown by Value for Ningbo Hi-Tech Biochemicals Co, Ltd., Staidson (Beijing) Biopharmaceuticals Co, Ltd., Xiamen Bioway Pku Co, Ltd., and Others......81
Table 80: Market Shares of Leading Pulmonary/ Alpha-1 Proteinase Inhibitor (A1PI) Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Limited, and Grifols, S.A.......82
Table 81: Grifols, S.A.'s Sales by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for European Union, US and Canada, and Others......83
Table 82: Grifols, S.A.'s Sales by Segment Worldwide (2015) - Percentage Market Share Breakdown by Value for Bioscience, Diagnostic, Hospital, and Others......84
Table 83: Grifols, S.A.'s Sales by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Immunoassay, Nucleic Acid Amplification Techniques Intellectual Property (NAT IP) Royalties, and Nucleic Acid Amplification Techniques (NAT)......85